B-flexion
Holding Companies & Conglomerates · Switzerland · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Av. Giuseppe Motta 31/33, Geneva, Geneva...Phone Number
+41 589440400Website
www.bflexion.comRevenue
$58.3 MillionIndustry
About B-flexion
B-flexion Org Chart
Is B-flexion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if B-flexion had a recent Job posting/layoffs
B-flexion, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once B-flexion has new funding data
Congratulate Masked Content for being promoted to Masked Content at B-flexion
Product Launch: Get notified when B-flexion launches new products
Earning: See what the market has to say on B-flexion recently announced quarterly report
Check out if B-flexion is spiking on competitors!
Check if B-flexion has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to B-flexion
Compare insights from companies similar to B-flexion, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
B-flexion is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.
What does this means?
B-flexion is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about B-flexion.
B-flexion Tech Stack
A closer look at the technologies used by B-flexion
B-flexion News & Media
Blackstone Credit & Insurance Leads $1.3 Billion Financing to Support Combination of ...
Press releases, portfolio company news, and timely updates on our business.Paratek Pharmaceuticals Completes Combination with Radius Health, Expanding Its Multi-Product Specialty Commercial Platform
Paratek Pharmaceuticals Completes Combination with Radius HealthB-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health
Transaction follows three years of accelerated growth and successful operations under B‑FLEXION and Patient Square's ownership. BOSTON, Jan. 12, 2026 /PRNewswire/ -- Radius Health ("Radius" or "the Company"), a specialty biopharmaceutical company dedicated to bone health and related...Boston Pharmaceuticals Announces Former NIH Director, Dr. Elias Zerhouni, As the New Chair of Its Board of Directors
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Boston Pharmaceuticals, a clinical-stage biopharmaceutical company developing differentiated molecules addressing serious liver diseases, has today named Dr. Elias Zerhouni as the new Chair of its Board of Directors, with Stefan Meister standing down from the Board after six years to focus on his ongoing roles elsewhere. Dr. Zerhouni has been a Board member and Scientific Advisor at Boston Pharmaceuticals since 2021. In assuming the position of Chair, he will
Top Holding Companies & Conglomerates Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding B-flexion
B-FLEXION oversees growth-oriented operating businesses and asset managers, always with an ‘active owner’ philosophy.... Read More